Max Robotics — Global Service Robot Directory + US Certification

About

Mark Sywak is a leading endocrine surgeon whose research focuses on minimally invasive surgical management of adrenal and thyroid disorders, with particular emphasis on pheochromocytoma and obesity-related outcomes. His major contributions include pioneering international multicenter studies that evaluate the safety and efficacy of robotic and laparoscopic adrenalectomy for pheochromocytoma, demonstrating that these approaches offer comparable outcomes to traditional open surgery with reduced morbidity. His 2024 study on robotic and laparoscopic adrenalectomy for pheochromocytoma, with 12 citations, provides critical evidence supporting the adoption of minimally invasive techniques in complex adrenal surgery. Additionally, his analysis of outcomes for patients with obesity undergoing adrenalectomy for pheochromocytoma, cited 7 times, addresses a significant gap in surgical care for this high-risk population. Sywak’s work has shaped clinical guidelines and improved perioperative management, making him a respected authority in endocrine surgery. His collaborative, data-driven research continues to influence surgical practice worldwide, benefiting both patients and the broader surgical community.